David Abrams Teva Pharmaceutical Industries LTD Transaction History

Abrams Capital Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$8.12 - $10.63 $16 Million - $20.9 Million	-1,969,597 Reduced 24.72%	5,996,836 $62.6 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $66.6 Million - $90.6 Million	-7,966,432 Reduced 50.0%	7,966,433 $70.5 Million
Q4 2022 Feb 10, 2023	SELL	$7.95 - $9.48 $63.3 Million - $75.5 Million	-7,966,431 Reduced 33.33%	15,932,865 $145 Million
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $1.01 Million - $1.76 Million	-147,060 Reduced 0.61%	23,899,296 $193 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $37 Million - $57.6 Million	6,000,000 Added 33.25%	24,046,356 $165 Million
Q1 2019 May 10, 2019	SELL	$15.58 - $20.01 $7.42 Million - $9.53 Million	-476,016 Reduced 2.57%	18,046,356 $283 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $14.6 Million - $23.8 Million	-1,000,000 Reduced 5.12%	18,522,372 $286 Million
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $4.65 Million - $5.66 Million	-220,751 Reduced 1.12%	19,522,372 $421 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $21.1 Million - $35.9 Million	-1,880,763 Reduced 8.7%	19,743,123 $374 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $333 Million - $696 Million	21,623,886	21,623,886 $381 Million

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Abrams Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Abrams Capital Management, L.P. and David Abrams with notifications on news.